Clinical Trials

Showing trials with last updates posted in 2025.

NCT07175415 | NOT_YET_RECRUITING | PHASE1/PHASE2
42 participants

HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-16
Start Date:
2026-10-01
Completion:
2031-10-01
Conditions
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent
  • Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory
  • Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent
  • Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory
Interventions
  • DRUG
  • DEVICE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page